CenterBook Partners
TXG icon

CenterBook Partners’s 10x Genomics TXG Stock Holding History

CenterBook Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$456K Sell
5,045
-16,192
-76% -$947K 0.02% 665
2026
Q2 		$814K Buy
+21,237
New +$557K 0.04% 402
2026
Q1 		– Sell
-230,772
Closed -$3.76M – 783
2025
Q4 		$3.76M Buy
+230,772
New +$3.49M 0.18% 155

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

CenterBook Partners's TXG Position: Q3 2026 in Review

CenterBook Partners reduced its 10x Genomics (TXG) stake by 76% in Q3 2026, selling an estimated $947K and leaving 5,045 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #665.

CenterBook Partners first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.76M in Q4 2025. 252 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • CenterBook Partners held 5,045 shares of 10x Genomics worth $456K as of Q3 2026.
  • CenterBook Partners sold 16,192 10x Genomics shares in Q3 2026, an estimated $947K.
  • 10x Genomics made up 0.02% of CenterBook Partners's portfolio in Q3 2026, its #665 holding.
  • CenterBook Partners first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • CenterBook Partners's 10x Genomics position peaked at $3.76M in Q4 2025.
  • 252 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.